Statistical Considerations in Early Phase Clinical Trial Design in the Era of Targeted Therapy and Immunotherapy

Statistical Considerations in Early Phase Clinical Trial Design in the Era of Targeted Therapy and Immunotherapy

0% Complete

Course Content

Credits

  • AMA PRA Category 1 Creditâ„¢Non-CME

Course Details

Duration
0.00 hour
Released
May 14, 2025
Last Review
May 14, 2025
Expires
May 14, 2028

Faculty & Disclosure

Faculty

Mark Krailo (USC)

Disclosure

Mark Krailo (USC) discloses no such relationships exist

Accreditation

NA